| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.08. | SOLESENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.08. | Solesence Reports Q2 2026 Results: Full Earnings Call Transcript | 4 | Benzinga.com | ||
| 19.08. | Solésence, Inc.: Solésence Reports Second Quarter 2026 Financial Results | 335 | GlobeNewswire (Europe) | Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically... ► Artikel lesen | |
| 19.08. | Solesence reports Q2 results | 1 | Seeking Alpha | ||
| 19.08. | SOLESENCE, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| SOLESENCE Aktie jetzt für 0€ handeln | |||||
| 13.07. | Solésence, Inc.: Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp | 4 | GlobeNewswire (USA) | ||
| 10.07. | SOLESENCE, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 18.06. | Solésence, Inc.: Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards | 7 | GlobeNewswire (USA) | ||
| 19.05. | Solésence, Inc.: Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Alle Awards, Marking Fourth Year of Recognition | 3 | GlobeNewswire (USA) | ||
| 15.05. | Solésence, Inc.: Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition | 2 | GlobeNewswire (USA) | ||
| 12.05. | SOLESENCE, INC. - 10-Q, Quarterly Report | 4 | SEC Filings | ||
| 12.05. | Solesence targets 30% gross margin floor while aiming to return to double-digit EBITDA margins by year-end 2026 | 2 | Seeking Alpha | ||
| 12.05. | Solesence GAAP EPS of -$0.01, revenue of $13M | 2 | Seeking Alpha | ||
| 12.05. | Solesence: Umsatzrückgang und Ergebnisverlust in Q1 2026 belasten Aktie | 4 | Investing.com Deutsch | ||
| 12.05. | Solesence Reports Q1 2026 Results: Full Earnings Call Transcript | 2 | Benzinga.com | ||
| 12.05. | SOLESENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.05. | Solésence, Inc.: Solésence Launches New Skin Health Technologies: WHSPR and Chromalüm | 8 | GlobeNewswire (USA) | ||
| 29.04. | SOLESENCE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.04. | Solésence verstärkt Verwaltungsrat mit Finanzexperte Marc James | 12 | Investing.com Deutsch | ||
| 27.04. | Solésence, Inc. Announces Appointment of New Independent Director | 9 | GlobeNewswire (USA) |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 19,920 | +0,61 % | BERENBERG stuft Formycon auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für das Biosimilar-Unternehmen Formycon nach Zahlen mit einem Kursziel von 30 Euro auf "Buy" belassen. Analyst Christian Ehmann... ► Artikel lesen | |
| ONTO INNOVATION | 232,70 | -0,43 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| KOPIN | 3,892 | +0,54 % | Fabric.AI (Nasdaq: FABC) Stockholders Ratify Kopin Strategic Partnership to Develop Neural I/o MicroLED Optical Interconnect Technology for Next Generation AI Data Centers | NEW YORK, NY, June 24, 2026 (GLOBE NEWSWIRE) -- Fabric.AI, Inc. (Nasdaq: FABC) ("Fabric.AI" or the "Company"), a fabless semiconductor company developing MicroLED-based optical interconnects for AI... ► Artikel lesen | |
| GAUZY | 0,390 | -0,31 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Delayed Filing of Annual Report on Form 20-F | TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that on May 19, 2026... ► Artikel lesen | |
| RIBER | 8,630 | 0,00 % | RIBER: FIRST-HALF 2026 BUSINESS ACTIVITY Business growth, resilient order book and continued rollout of ROSIE | FIRST-HALF 2026 BUSINESS ACTIVITYBusiness growth, resilient order book and continued rollout of ROSIE Bezons, July 22, 2026 - 8:00 am - RIBER, the global leader in molecular beam epitaxy (MBE) equipment... ► Artikel lesen | |
| NVE | 88,00 | +0,57 % | Dividendenbekanntmachungen (03.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,026 EUR BF SPA IT0005187460 - 0,038 EUR CITIZENS & NORTHERN CORPORATION US1729221069 0... ► Artikel lesen | |
| VEECO INSTRUMENTS | 39,980 | +4,55 % | Veeco Instruments Inc.: Veeco Reports Second Quarter 2026 Financial Results | Second Quarter 2026 Highlights: Revenue of $193.5 million, compared with $166.1 million in the same period last yearGAAP net income of $11.9 million, or $0.18 per diluted share, compared with $11.7... ► Artikel lesen | |
| CANATU | 5,390 | -0,74 % | Canatu Oyj: Canatu's Half-year financial report January-June 2026: A pivotal period - sharpening Canatu's path to scalable growth; updated 2026 outlook | Canatu Plc Company release 25 August 2026 at 9:00 am EEST
Canatu's Half-year financial report January-June 2026: A pivotal period - sharpening Canatu's path to scalable growth; updated 2026 outlook
This... ► Artikel lesen | |
| NANOVIRICIDES | 1,050 | -1,87 % | NanoViricides: The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon | SHELTON, CT / ACCESS Newswire / August 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that... ► Artikel lesen | |
| GOMSPACE | 1,034 | +1,08 % | GomSpace Group AB: Q2 Financial Reporting Confirms a Strong First Half of 2026: 30% Growth, Positive EBIT, Reinforced Balance Sheet and Guidance Maintained | GomSpace posts above-market 30% revenue growth, improved profitability with 11% EBITDA and positive EBIT, and a strengthened balance sheet with equity ratio increase to 41%, while progressing its shift... ► Artikel lesen | |
| SMOLTEK NANOTECH | 0,110 | -0,45 % | SMOLTEK NANOTECH HOLDING AB: Smoltek presents Q2 report at Redeye | ||
| NANOVEU | 0,042 | +31,25 % | NANOVEU LIMITED: Half Yearly Report and Accounts | ||
| LAMPETIA | 0,186 | +15,53 % | EQS-Adhoc: Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Sonstiges
Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten
16.07.2026 / 22:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,136 | 0,00 % | FendX Technologies Inc.: FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program | Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection... ► Artikel lesen | |
| DOTZ NANO | 0,013 | -6,02 % | DOTZ NANO LIMITED: Cleansing Notice |